Prelude Therapeutics (PRLD) Leases (2024 - 2025)
Historic Leases for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $27.5 million.
- Prelude Therapeutics' Leases fell 559.59% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 559.59%. This contributed to the annual value of $28.7 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, Prelude Therapeutics' Leases stood at $27.5 million, which was down 559.59% from $27.9 million recorded in Q2 2025.
- In the past 5 years, Prelude Therapeutics' Leases ranged from a high of $30.1 million in Q1 2024 and a low of $27.5 million during Q3 2025